Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 13 July 2005. doi:10.1136/ard.2004.033837
Annals of the Rheumatic Diseases 2006;65:178-183
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism.

EXTENDED REPORT

Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjögren’s syndrome: association with mononuclear cell infiltration

C Molina2, C Alliende3, S Aguilera1, Y-J Kwon3, L Leyton3, B Martínez2, C Leyton3, P Pérez3, M-J González3

1 Department of Rheumatology, INDISA Clinic, Andrés Bello University, Santiago, Chile
2 Department of Oral Pathology, Mayor University, Santiago, Chile
3 Programme of Cell and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile

Correspondence to:
Professor María-Julieta González
Programme of Cell and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70061, Santiago 7, Chile; jgonzale{at}med.uchile.cl

Objective: To study the expression of laminin and type IV collagen as biomarkers of the organisation of the basal lamina of acini and ducts in labial salivary glands from patients with Sjögren’s syndrome, and to relate this organisation to inflammatory cell invasion of acini and ducts.

Methods: Immunohistochemistry for laminin and type IV collagen was undertaken on sections of labial salivary glands from 30 patients with Sjögren’s syndrome, 10 control subjects, and 24 controls with chronic sialoadenitis. Immunohistochemistry reaction, alterations to cell morphology, and the presence of inflammatory cells in acini and ducts were evaluated and scored using a semiquantitative method.

Results: Changes in the expression of laminin and type IV collagen in the basal lamina of acini and ducts of labial salivary glands from patients with Sjögren’s syndrome were more pronounced than in labial salivary glands from control groups. A remarkable characteristic was the disorganisation of the basal lamina in the labial salivary glands in Sjögren’s syndrome. The pattern of immunoreactivity of the basal lamina of other structures (for example, blood vessels) did not change. In Sjögren’s syndrome, invasion of cytotoxic T lymphocytes was only observed in acini and ducts which had a disorganised basal lamina.

Conclusions: The high state of disorganisation of the basal lamina of acini and ducts could allow invasion of cytotoxic T lymphocytes in Sjögren’s syndrome, contributing to cell death and ductal hyperplasia.

Abbreviations: IHR, immunohistochemical reaction; MMP, matrix metalloproteinase

Keywords: basal lamina; salivary gland; Sjögren’s syndrome


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Velozo, J, Aguilera, S, Alliende, C, Ewert, P, Molina, C, Perez, P, Leyton, L, Quest, A, Brito, M, Gonzalez, S, Leyton, C, Hermoso, M, Romo, R, Gonzalez, M-J (2009). Severe alterations in expression and localisation of {alpha}6{beta}4 integrin in salivary gland acini from patients with Sjogren syndrome. Ann Rheum Dis 68: 991-996 [Abstract] [Full Text]  
  • Sisto, M., D'Amore, M., Lofrumento, D. D., Scagliusi, P., D'Amore, S., Mitolo, V., Lisi, S. (2009). Fibulin-6 expression and anoikis in human salivary gland epithelial cells: implications in Sjogren's syndrome. Int Immunol 21: 303-311 [Abstract] [Full Text]  
  • Alliende, C, Kwon, Y-J, Brito, M, Molina, C, Aguilera, S, Perez, P, Leyton, L, Quest, A F G, Mandel, U, Veerman, E, Espinosa, M, Clausen, H, Leyton, C, Romo, R, Gonzalez, M-J (2008). Reduced sulfation of muc5b is linked to xerostomia in patients with Sjogren syndrome. Ann Rheum Dis 67: 1480-1487 [Abstract] [Full Text]  
  • Walsh, C. A. E., Minnock, P., Slattery, C., Kennedy, N., Pang, F., Veale, D. J., Bresnihan, B., FitzGerald, O. (2007). Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis. Rheumatology (Oxford) 46: 1148-1152 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs